Welireg Drug Interactions
Currently displaying a list of 386 drugs known to interact with Welireg (belzutifan).
- 80 major drug interactions
- 294 moderate drug interactions
- 12 minor drug interactions
Medications known to interact with Welireg
Note: Showing generic names only.
A
- abiraterone
- acalabrutinib
- ado-trastuzumab emtansine
- albendazole
- alfentanil
- alpelisib
- alprazolam
- amiodarone
- amlodipine
- amprenavir
- apalutamide
- apixaban
- apremilast
- aprepitant
- aripiprazole
- armodafinil
- astemizole
- atazanavir
- atogepant
- atorvastatin
- avacopan
- avanafil
- avapritinib
- avatrombopag
- axitinib
B
- bedaquiline
- belumosudil
- bepridil
- betamethasone
- bexarotene
- boceprevir
- bortezomib
- bosentan
- bosutinib
- brentuximab
- brexpiprazole
- brigatinib
- bromocriptine
- budesonide
- buprenorphine
- buspirone
- butorphanol
C
- cabazitaxel
- cabozantinib
- cannabidiol
- capivasertib
- capmatinib
- carbamazepine
- cariprazine
- cenobamate
- ceritinib
- cerivastatin
- cevimeline
- chloramphenicol
- chlorotrianisene
- cimetidine
- cinacalcet
- cisapride
- citalopram
- clarithromycin
- clonazepam
- clorazepate
- cobicistat
- cobimetinib
- codeine
- colchicine
- conivaptan
- conjugated estrogens
- cortisone
- crizotinib
- cyclosporine
D
- dabrafenib
- daclatasvir
- darbepoetin alfa
- daridorexant
- darifenacin
- darolutamide
- darunavir
- dasatinib
- deflazacort
- dehydroepiandrosterone
- delavirdine
- dexamethasone
- dienestrol topical
- dihydroergotamine
- diltiazem
- divalproex sodium
- docetaxel
- dofetilide
- donepezil
- doravirine
- doxazosin
- doxercalciferol
- doxorubicin
- doxorubicin liposomal
- dronedarone
- drospirenone
- dutasteride
- duvelisib
E
- efavirenz
- elacestrant
- eletriptan
- eliglustat
- enfortumab vedotin
- entrectinib
- enzalutamide
- eplerenone
- epoetin alfa
- epoetin beta-methoxy polyethylene glycol
- ergonovine
- ergotamine
- erlotinib
- erythromycin
- eslicarbazepine
- esomeprazole
- estazolam
- estradiol
- estradiol topical
- estrone
- estropipate
- eszopiclone
- ethinyl estradiol
- ethosuximide
- etonogestrel
- etoposide
- etravirine
- everolimus
- exemestane
F
- fedratinib
- felbamate
- felodipine
- fenfluramine
- fenofibrate
- fentanyl
- fesoterodine
- fexinidazole
- finerenone
- flibanserin
- fluconazole
- fludrocortisone
- fluoxetine
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fostemsavir
G
H
I
- ibrexafungerp
- ibrutinib
- idelalisib
- iloperidone
- imatinib
- indacaterol
- indinavir
- infigratinib
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isoniazid
- isotretinoin
- isradipine
- istradefylline
- itraconazole
- ivabradine
- ivacaftor
- ivermectin
- ixabepilone
- ixazomib
K
L
- lacosamide
- lansoprazole
- lapatinib
- larotrectinib
- lemborexant
- lenacapavir
- leniolisib
- letrozole
- levobupivacaine
- levomethadyl acetate
- levonorgestrel
- lidocaine
- linagliptin
- lomitapide
- lonafarnib
- loratadine
- lorlatinib
- lovastatin
- lumateperone
- lurasidone
M
- macitentan
- maraviroc
- maribavir
- mavacamten
- medroxyprogesterone
- mefloquine
- megestrol
- methadone
- methylergonovine
- methylprednisolone
- methysergide maleate
- mibefradil
- midazolam
- midostaurin
- mifepristone
- mirabegron
- mirtazapine
- mitapivat
- mobocertinib
- modafinil
- mometasone
- montelukast
N
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nintedanib
- nirogacestat
- nisoldipine
- nitisinone
- norethindrone
- norgestrel
O
- olaparib
- oliceridine
- olutasidenib
- omaveloxolone
- omeprazole
- ondansetron
- oritavancin
- osilodrostat
- osimertinib
- oxcarbazepine
- oxybutynin
- oxycodone
P
- paclitaxel
- paclitaxel protein-bound
- palbociclib
- palovarotene
- panobinostat
- paricalcitol
- pazopanib
- peginesatide
- pemigatinib
- perampanel
- pexidartinib
- pimozide
- pirtobrutinib
- pitolisant
- polatuzumab vedotin
- pomalidomide
- ponatinib
- ponesimod
- pralsetinib
- praziquantel
- prednisolone
- prednisone
- pretomanid
- progesterone
- progesterone topical
Q
R
- rabeprazole
- ramelteon
- ranolazine
- red yeast rice
- regorafenib
- relugolix
- repaglinide
- repotrectinib
- retapamulin topical
- ribociclib
- rifabutin
- rifampin
- rilpivirine
- rimegepant
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- roflumilast
- rolapitant
- romidepsin
- ropivacaine
- rucaparib
- ruxolitinib
S
- salmeterol
- saquinavir
- saxagliptin
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- sildenafil
- silodosin
- simvastatin
- siponimod
- sirolimus
- sirolimus protein-bound
- solifenacin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- stiripentol
- sufentanil
- sunitinib
- suvorexant
T
- tacrolimus
- tadalafil
- tamoxifen
- tamsulosin
- tasimelteon
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- temsirolimus
- teniposide
- terfenadine
- testosterone
- testosterone topical
- tiagabine
- ticagrelor
- ticlopidine
- tinidazole
- tipranavir
- tofacitinib
- tolterodine
- tolvaptan
- toremifene
- trabectedin
- tramadol
- trazodone
- tretinoin
- triamcinolone
- triazolam
- troglitazone
- troleandomycin
- tucatinib
U
V
- valbenazine
- valdecoxib
- valproic acid
- vandetanib
- vardenafil
- vemurafenib
- venetoclax
- venlafaxine
- verapamil
- vilazodone
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voclosporin
- vonoprazan
- vorapaxar
- voriconazole
- voxelotor
W
Z
Welireg disease interactions
There are 4 disease interactions with Welireg (belzutifan) which include:
More about Welireg (belzutifan)
- Welireg consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.